Covaxin Trial
-
{
- All
- News
- Videos
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
-
Covaxin Trial On 2-18 Year Olds "Amounts To Homicide": Plea In Delhi High Court
A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Covid Positive Haryana Home Minister Anil Vij Stable, Likely To Be Discharged Soon
Haryana Home and Health Minister Anil Vij, who has been undergoing treatment for Covid at a Gurugram hospital since December 15, is likely to be discharged in the next few days as doctors attending to him are satisfied with the progress in his health.
-
"Robust Immune Responses": Indian Vaccine-Maker After Test On Monkeys
Bharat Biotech that is developing the coronavirus vaccine COVAXIN in its latest report has said an animal study has shown a vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus.
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
-
Covaxin Trial On 2-18 Year Olds "Amounts To Homicide": Plea In Delhi High Court
A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
-
Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its phase 2 results.
-
Covid Positive Haryana Home Minister Anil Vij Stable, Likely To Be Discharged Soon
Haryana Home and Health Minister Anil Vij, who has been undergoing treatment for Covid at a Gurugram hospital since December 15, is likely to be discharged in the next few days as doctors attending to him are satisfied with the progress in his health.
-
"Robust Immune Responses": Indian Vaccine-Maker After Test On Monkeys
Bharat Biotech that is developing the coronavirus vaccine COVAXIN in its latest report has said an animal study has shown a vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus.
